2021-11-16-世界卫生组织-Cervical_cancer_Democratic_Republic_of_the_Congo_2021_country_profile_1页_64kb

Cervical Cancer Profile Summary for DRC

Burden of Disease

• High age-standardized incidence rate (31.9 per 100,000 women in 2020).
• Estimated 4,800 cervical cancer deaths in 2019.
• Morbidity-to-incidence ratio of 0.71 in 2020.
• Limited population-based cancer registry data.

Prevention Efforts

• Primary prevention: HIV incidence high (0.29% women aged 15+), tobacco use prevalence high (no specific 2020 data), and condom use low (average from 2013-2014 not detailed).
• HPV vaccination: National schedule does not include HPV, and coverage is minimal (3% of target girls vaccinated by age 14; only 20% completed both doses, coverage under 40%).
• No formal HPV inclusion plan.

Prevention Screening

• No national cervical cancer screening program as of 2021.
• Primary screening test not specified, and target age range undefined.
• Low screening awareness, with <10% of women believed to use effective tests by ages 35 and 45, and 90% reporting no recent screening.

Treatment and Supportive Care

• Radiotherapy and brachytherapy units are insufficient (less than 1 per 10,000 patients).
• No national cervical cancer management guidelines, and no tertiary cancer centers.
• Shortage of specialized staff supporting cancer diagnosis and treatment.
• Palliative care availability not reported.

Elimination Strategy Progress

• Fails to meet WHO 2030 targets, marked by lack of national prevention programs, low resources, and limited screening/treatment infrastructure.